CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Pfizer Inc. vs. Amgen Inc

Explore the PTAB proceeding IPR2021-00528 filed by Pfizer Inc. on 2021-02-10. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2021-00528

Filing Date

2021-02-10

Accorded Filing Date

2021-02-10

Institution Decision Date

2021-08-17

Last Modified Date

2022-04-20

Proceeding Type

IPR

Termination Date

2022-04-20

Trial Status

Terminated-Settled

Parties & Counsel

Petitioner

Pfizer Inc.

Represented By

Alison Hanstead

Patent Owner / Respondent

Amgen Inc

Represented By

J. Steven Baughman

Patent Information

1 Patent Involved
Respondent Application Number 12822072
Respondent Patent Number 8273707
Legal Expiration Date
2024-09-14 Expired (Term Ended)
Injunction Viability (35 U.S.C. ยง 283) Statutorily Barred
Respondent Inventor Anna Senczuk et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

0 Total

Proceeding Status

Terminated-Settled

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Address and Attorney/Agent Information

41 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name AMGEN INC.
Customer Number 21069
Address Law - Patent Operations, M/S 28-5-A, One Amgen Center Drive, Thousand Oaks, CA, 91320-1799, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
32511 Stuart Watt +1 805-447-2154
36964 Wendy Whiteford +1 805-447-1008
38496 Petrina Hsi +1 805-447-8631
41156 Susan Lingenfelter +1 805-313-3010
41576 Lisa Alexander +1 650-244-2968
44412 Henry Wu +1 805-447-0781
44689 Bernard Friedrichsen +1 805-447-0628
45590 Randolph Mohr +1 805-447-8949

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts 2 proceedings
๐Ÿ›๏ธ
USPTO PTAB Trials Counterparts in force
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (2 found):
U.S. Courts: 2
U.S. District Court 2020-02-11
1:20-cv-00201

Amgen Inc. v. Hospira, Inc.

Asserted Patent
Status: DED
U.S. District Court 2017-09-22
2:17-cv-01235

AMGEN INC v. MYLAN INC.

Asserted Patent
Status: PAWD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

89
36

TERMINATION Due to Settlement After Institution of Trial 35 U.S.C. 317; 37 C.F.R. 42.74 Paper

2022-04-20 FILING PARTY: BOARD
35

April 15, 2022 Joint Stipulation to Modify Due Dates 3, 5, and 6 Paper

2022-04-15 FILING PARTY: PATENT OWN
34

April 8, 2022 Joint Stipulation to Modify Due Date 3 Paper

2022-04-08 FILING PARTY: PATENT OWN
33

Patent Owner's Request for Oral Argument Paper

2022-04-05 FILING PARTY: PATENT OWN
32

March 25, 2022 Joint Stipulation to Modify Due Date 3 MOTION

2022-03-25 FILING PARTY: PATENT OWN

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc